Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
A phase 2 trial of Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell) in sarcomas, run by CNBG-Virogin Biotech (Shanghai) Ltd., now recruiting.
Overview
Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma is a phase 2 interventional study registered as NCT06126510 by CNBG-Virogin Biotech (Shanghai) Ltd., with 40 participants planned, started 2023-07-18 and due to reach its primary completion in 2025-07-17. Interventions recorded: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell).
Similar pages
not linked directly; found by shared links- TrialA Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialFirst-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialIvosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialSpearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialA Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialA Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.